Andreas Liebl
Bad Heilbrunn, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Efficacy and Safety of Intensifying Once-Weekly Insulin Icodec Treatment With Once-Weekly Semaglutide in Adults With Type 2 Diabetes: A Single-Arm, Open-Label, Treat-to-Target, Phase 3b Trial (ONWARDS 8).
Journal: Diabetes, obesity & metabolism
Published: April 13, 2026
Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed-Dose Titration of Weekly Insulin Efsitora in Insulin-Naïve Type 2 Diabetes.
Journal: Diabetes, obesity & metabolism
Published: December 02, 2025
Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes.
Journal: Journal of diabetes science and technology
Published: January 30, 2023
Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: November 18, 2021
Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study).
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: October 07, 2021
New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion.
Journal: Journal of diabetes science and technology
Published: June 15, 2019
The relation between the intelligibility of irrelevant speech and cognitive performance-A revised model based on laboratory studies.
Journal: Indoor air
Published: April 14, 2019
EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: November 02, 2018
A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: September 13, 2018
15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes.
Journal: Drugs in R&D
Published: February 23, 2018
Last Updated: 09/26/2026